TipRanks on MSN

NexGen Energy Awaits Final Approval for Rook I Project

NexGen Energy ( ($TSE:NXE) ) has shared an update. On November 19, 2025, NexGen Energy participated in the first of two Canadian Nuclear Safety ...

Eisai to Present Data on Lecanemab Continued Treatment, Subcutaneous Initiation Dosing, and Real-World Experience at the 18th Clinical Trials on Alzheimer's Diseas…

Eisai Inc. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will present the latest findings ...

New data on lecanemab to be presented at CTAD conference

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer's Disease (CTAD) conference, being held in ...